Published in Biochim Biophys Acta on May 11, 1973
Measurement of specific [3H]-ouabain binding to different types of human leucocytes. Br J Clin Pharmacol (1984) 1.56
Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes. J Physiol (1975) 1.42
The correlation between ouabain binding and potassium pump inhibition in human and sheep erythrocytes. J Physiol (1978) 1.41
Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart. J Clin Invest (1996) 1.04
Ouabain binding to renal tubules of the rabbit. J Cell Biol (1978) 0.97
Localization of Na pumps in the tracheal epithelium of the dog. J Cell Biol (1979) 0.95
Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1. Eur J Pharmacol (2009) 0.88
Transcellular sodium fluxes and pump activity in Necturus gall-bladder epithelial cells. J Physiol (1987) 0.86
Ouabain and regulation of cellular volume in slices of mammalian renal cortex. J Physiol (1981) 0.82
Ouabain receptor binding of hydroxyprogesterone derivatives. Br J Pharmacol (1979) 0.79
Reduced number of digitalis receptor sites in the hypertrophied pig myocardium. Basic Res Cardiol (1984) 0.77
Erythrosin B inhibits high affinity ouabain binding in guinea-pig heart Na+-K+-ATPase without influence on cardiac glycoside induced contractility. Br J Pharmacol (1985) 0.77
Effect of prolactin on 86Rb+ uptake, potassium content and [G-3H]ouabain binding of lactating rabbit mammary tissue. J Physiol (1983) 0.76
Ouabain attenuates ovalbumin-induced airway inflammation. Inflamm Res (2017) 0.75
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation (1992) 3.46
Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res (1993) 2.94
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. Dtsch Med Wochenschr (2007) 2.67
An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27
[The central venous catheter. Approach to the subclavian vein]. Dtsch Med Wochenschr (2007) 2.04
[Ascites paracentesis]. Dtsch Med Wochenschr (2007) 2.03
A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. Eur Heart J (1999) 1.98
On the mechanism of Na+- and K+-stimulated hydrolysis of adenosine triphosphate. 1. Purification and properties of a Na+-and K+-activated ATPase from ox brain. Eur J Biochem (1967) 1.92
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace (2007) 1.73
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res (1994) 1.66
Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol (1998) 1.64
CT and MR evaluation of pericardial constriction: a new diagnostic and therapeutic concept. J Thorac Imaging (1993) 1.64
Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol (1999) 1.63
A prognostic computer model to predict individual outcome in interventional cardiology. The INTERVENT Project. Eur Heart J (1997) 1.61
Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia. Eur Respir J (2011) 1.60
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res (1993) 1.55
Congenitally corrected transposition of the great arteries (L-TGA) with situs inversus totalis in adulthood: findings with magnetic resonance imaging. Magn Reson Imaging (2000) 1.52
Colocalization and coprecipitation of ankyrin and Na+,K+-ATPase in kidney epithelial cells. Eur J Cell Biol (1988) 1.50
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49
Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes. J Physiol (1975) 1.42
Xamoterol and the failing heart. Lancet (1989) 1.41
[About science and politics]. Dtsch Med Wochenschr (2003) 1.41
[Therapy with glitazones--a risk for cardiovascular disease?]. Dtsch Med Wochenschr (2007) 1.40
Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography. J Am Coll Cardiol (1999) 1.40
[Epileptic seizures: effects on cardiac function]. Dtsch Med Wochenschr (2011) 1.40
[Alcohol and myocardial infarct. Epidemiological and experimental studies on the effect of alcohol on vascular relaxation and coronary sclerosis]. Dtsch Med Wochenschr (1998) 1.39
Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting. Swiss Med Wkly (2009) 1.39
[Dissection of the ramus interventricularis anterior in blunt chest trauma]. Dtsch Med Wochenschr (1999) 1.39
[Clinical value of magnetic resonance tomography in imaging coronary stenoses. A comparison with coronary angiography and myocardial scintigraphy]. Dtsch Med Wochenschr (1999) 1.38
[Missing medical care?]. Dtsch Med Wochenschr (2002) 1.38
[Death due to liver hemorrhage after infarct lysis]. Dtsch Med Wochenschr (1999) 1.38
[Stable angina pectoris can be treated successfully by drugs alone--pro]. Dtsch Med Wochenschr (2007) 1.38
Increase of Gi alpha in human hearts with dilated but not ischemic cardiomyopathy. Circulation (1990) 1.36
The failing human heart is unable to use the Frank-Starling mechanism. Circ Res (1994) 1.31
[Guidelines for therapy of chronic heart failure]. Z Kardiol (2005) 1.24
Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol (1998) 1.22
Positive inotropism of vanadate in cat papillary muscle. Nature (1978) 1.18
Ca(2+)-currents and intracellular [Ca2+]i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Basic Res Cardiol (1992) 1.18
Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol (1996) 1.12
Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure. Circulation (1999) 1.11
Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J (1988) 1.10
Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol (1994) 1.10
Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart. Biochem Pharmacol (1980) 1.08
Evidence against spare or uncoupled beta-adrenoceptors in the human heart. Am Heart J (1990) 1.06
Effects of vanadate in cultured rat heart muscle cells. Vanadate transport, intracellular binding and vanadate-induced changes in beating and in active cation flux. Biochim Biophys Acta (1980) 1.05
Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet (1992) 1.04
Regional expression of sodium pump subunits isoforms and Na+-Ca++ exchanger in the human heart. J Clin Invest (1996) 1.04
Effects of cortisol on the levels of metabolites and enzymes controlling glucose production from pyruvate. Adv Enzyme Regul (1968) 1.01
[Characteristics of patients with coronary ectasias with and without stenotic coronary artery disease]. Dtsch Med Wochenschr (2005) 1.01
Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. J Mol Cell Cardiol (1997) 1.01
Stimulatory effect of vanadate on the adenylate cyclase of cardiac tissue. Biochem Pharmacol (1979) 0.99
Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol (1991) 0.99
Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol (1996) 0.99
Altered diastolic [Ca2+]i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J (1995) 0.99
Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res (1991) 0.99
Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J Biol Chem (1998) 0.99
Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation. J Cardiovasc Pharmacol (1988) 0.98
On the role of phosphorylated intermediates in sodium and potassium stimulated ATP-hydrolysis. Biochem Biophys Res Commun (1966) 0.98
Alcohol and the risk of myocardial infarction. Basic Res Cardiol (2001) 0.97
Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol (1995) 0.97
Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors. Biomed Biochim Acta (1983) 0.95
Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest (1990) 0.95
Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages. Eur Respir J (2004) 0.94
cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res (1994) 0.94
Echinococcus cyst located in the interventricular septum. Clin Res Cardiol (2006) 0.94
Inverse relationship between colonic (Na+ + K+)-ATPase activity and degree of mucosal inflammation in inflammatory bowel disease. Dig Dis Sci (1988) 0.93
A fresh facet for ouabain action. Nat Med (2001) 0.93
Ouabain-receptor interactions in (Na+ plus K+)-ATPase preparations. IV. The molecular structure of different cardioactive steroids and other substances and their affinity to the glycoside receptor. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.93
Pathologists' attitudes to implementing telepathology. J Telemed Telecare (1998) 0.93
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity. Am Heart J (1990) 0.93
[Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany]. Dtsch Med Wochenschr (2007) 0.93
Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol (1988) 0.92
Baseline characteristics of patients recruited into the CARE-HF study. Eur J Heart Fail (2005) 0.92
Increased number of ouabain binding sites in human erythrocyte membranes in chronic hypokalaemia. Acta Biol Med Ger (1977) 0.91
Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts. Circ Res (1989) 0.90
Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J (1996) 0.90
Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation. Nature (1979) 0.90
Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. A possible diarrhogenic factor? Clin Investig (1993) 0.89
Ouabain-receptor interactions in (Na+ + K+)-ATPase preparations. II. Effect of cations and nucleotides on rate constants and dissociation constants. Biochim Biophys Acta (1973) 0.89
Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail (2004) 0.89
International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study. Heart European Leaders Panel. J Cardiovasc Risk (1999) 0.88
Calcium sensitivity and myosin light chain pattern of atrial and ventricular skinned cardiac fibers from patients with various kinds of cardiac disease. J Mol Cell Cardiol (1990) 0.88
ADP binding to (Na++K+)-activated ATPase. Biochim Biophys Acta (1973) 0.88
Na+ channel activators as positive inotropic agents for the treatment of chronic heart failure. Cardiovasc Drugs Ther (2001) 0.88
Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. Am Heart J (1992) 0.88
Regulation of gluconeogenesis by alanine. Biochim Biophys Acta (1974) 0.87
On the mechanism of Na plus and K plus-stimulated hydrolysis of adenosine triphosphate. 2. Comparison of nucleotide specificities of Na plus and K plus-activated ATPase and Na plus-dependent phosphorylation of cell membranes. Eur J Biochem (1968) 0.87
Different beta-adrenoceptor-effector coupling in human ventricular and atrial myocardium. Eur J Clin Invest (1991) 0.87
Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)). Z Kardiol (2003) 0.86
Reduced positive inotropic effects in diseased human ventricular myocardium. Cardiovasc Res (1986) 0.86
Desensitization of adenylate cyclase and increase of Gi alpha in cardiac hypertrophy due to acquired hypertension. Hypertension (1992) 0.86